Food and Drug Administration reviewers said the Pfizer/BioNTech and Moderna COVID-19 vaccines are safe and effective for children under the age of six. The agency may authorize both vaccines this week. (Politico)

The FDA has approved Rune Lab’s Apple Watch software, StrivePD, for the tracking of Parkinson’s disease symptoms. The software uses Apple’s Movement Disorder API to analyze tremors and other symptoms of the disease, which can help patients monitor their medication. (STAT)

Canada has approved Albrioza, an experimental therapy for amyotrophic lateral sclerosis. Albrioza is currently under review by the FDA, but thus far U.S. regulators have said its efficacy is unproven. (The New York Times)

Day One Biopharmaceuticals announced its pediatric cancer drug showed promising results in a Phase II trial. Among patients with recurrent or progressive low-grade glioma, the drug showed an overall response rate of 64%. (Endpoints News)

As the COVID-19 pandemic has abated, other viruses, including influenza, RSV, tuberculosis and monkeypox, have returned in different forms. “We’re seeing viruses behave in very odd ways that they weren’t before,” said Yale New Haven Hospital’s Dr. Scott Roberts. (CNBC Weekly).